Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Wockhardt Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.

Key Information

Market Cap

278062301184

Current Price

1711.3

52 Week Range

825.0 - 1868.8

Previous Close

1733.0

Open

1740.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Wockhardt Towers, Bandra Kurla Complex Bandra (East), Mumbai, 400051, India

Phone

+91-24066-94444

Fax

+91-24024-89219

Website

https://www.wockhardt.com

Financials

Day Low

1699.8

Day High

1750.0

Dividend Yield

PE Ratio

Earnings Per Share

-2.95

Beta

1.182

EBITDA

3600000000

Book Value

263.839

EPS

Company Officers

Name	Title	Age	Year Born
Dr. Habil Fakhruddin Khorakiwala	Founder & Executive Chairman	83	1941
Dr. Murtaza Habil Khorakiwala	MD & Executive Director	51	1973
Dr. Huzaifa Habil Khorakiwala	Executive Director	53	1971
Mr. Deepak R. Madnani	Chief Financial Officer	-	-
Dr. Sachin Bhagwat	Chief Scientific Officer	-	-
Ms. Debolina Partap	Senior Vice President of Legal	-	-
Mr. Satej Mehta	Head of Human Resource	-	-
Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA	Senior Vice President of Business Development	73	1951
Mr. Zoher T. Sihorwala	Head of Global Regulatory Affairs	54	1970
Mr. Prakash Gupta	President of Supply Chain	-	-